Omega Healthcare Reports Q3 2026 Results with Increased Full-Year AFFO Guidance
Omega Healthcare (OHI) reported third-quarter revenue of $341 million, up from $312 million in the prior year, driven by higher resident fees and services income. While net income decreased to $83 million due to $60 million in transition-related expenses and the absence of a previous year's gain, core performance remained robust. Adjusted Funds From Operations (AFFO) reached $0.82 per share, and Funds Available for Distribution (FAD) grew to $0.78 per share compared to last year. The company demonstrated strong balance sheet management, reporting its lowest leverage ratio in history at 3.1x and a decade-high fixed charge coverage of 6.9x. Following these results, Omega Healthcare raised its full-year AFFO guidance to a midpoint of $3.29 per share. Strategic moves included the transition of 32 Florida facilities and significant investments in both U.S. and UK real estate markets.
Tickers: $OHI
Topics: AFFO guidance asset transition net income decrease revenue growth